 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Beta-lactamase toho-1 from escherichia coli tuh12191
|
|
Structure:
|
 |
Beta-lactamase. Chain: a. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Escherichia coli. Organism_taxid: 562. Strain: tuh12191. Cellular_location: periplasm. Gene: bla. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
1.80Å
|
R-factor:
|
0.182
|
R-free:
|
0.217
|
|
|
Authors:
|
 |
A.Ibuka,A.Taguchi,M.Ishiguro,S.Fushinobu,Y.Ishii,S.Kamitori, K.Okuyama,K.Yamaguchi,M.Konno,H.Matsuzawa
|
Key ref:
|
 |
A.Ibuka
et al.
(1999).
Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 A resolution.
J Mol Biol,
285,
2079-2087.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
28-Oct-98
|
Release date:
|
27-Apr-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
Q47066
(BLT1_ECOLX) -
Beta-lactamase Toho-1
|
|
|
|
Seq: Struc:
|
 |
 |
 |
291 a.a.
257 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
response to antibiotic
|
2 terms
|
 |
|
Biochemical function
|
hydrolase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
285:2079-2087
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 A resolution.
|
|
A.Ibuka,
A.Taguchi,
M.Ishiguro,
S.Fushinobu,
Y.Ishii,
S.Kamitori,
K.Okuyama,
K.Yamaguchi,
M.Konno,
H.Matsuzawa.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Bacterial resistance to beta-lactams is mainly due to the production of
beta-lactamase. Especially through the production of extended-spectrum
beta-lactamases (ESBLs), bacteria have acquired resistance not only to
penicillins, but also to expanded-spectrum cephems. Here, we describe the
crystal structure of the E166A mutant of class A beta-lactamase Toho-1 at 1.8 A
resolution, the first reported tertiary structure of an ESBL. Instead of the
wild-type enzyme, a mutant Toho-1, in which Glu166 was replaced with alanine,
was used for this study, because of the strong tendency of the wild-type enzyme
to form twinned crystals. The overall structure of Toho-1 is similar to the
crystal structures of non-ESBLs, with no pronounced backbone rearrangement of
the framework. However, there are some notable local changes. First, a
difference in the disposition of an arginine residue, which is at position 244
in non-ESBLs but at position 276 in Toho-1 and other ESBLs, was revealed and the
role of this arginine residue is discussed. Moreover, changes in the
hydrogen-bonding pattern and in the formation of the hydrophobic core were also
observed near the Omega loop. In particular, the lack of hydrogen bonds in the
vicinity of the Omega loop could be a cause of the extended substrate
specificity of Toho-1. Through the generation of a model for the
enzyme-substrate complex, a conformational change of Toho-1 occurring on complex
formation is discussed based on the active-site cleft structure and the
substrate profile.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. A stereo view of the hydrogen-bonding net-
work in the active-site cleft of Toho-1. Water oxygen
atoms are shown as red balls, and the hydrogen bonds
as broken lines. The sulfate ion is shown by sticks at
the center of the cleft. This Figure was generated with
MOLMOL (Koradi et al., 1996).
|
 |
Figure 5.
Figure 5. Hydrogen-bonding pat-
tern near Asp240. The main-chain
and hydrogen bonds of Toho-1 are
shown in blue and green, respect-
ively, and those of B. licheniformis
b-lactamase in pink and magenta.
The water molecule of Toho-1 is
colored red, and that of B. licheni-
formis b-lactamase pink.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1999,
285,
2079-2087)
copyright 1999.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Toth,
C.Smith,
H.Frase,
S.Mobashery,
and
S.Vakulenko
(2010).
An antibiotic-resistance enzyme from a deep-sea bacterium.
|
| |
J Am Chem Soc, 132,
816-823.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Cheng,
Q.Wang,
Y.Chen,
Y.Ye,
H.Li,
X.Li,
and
J.B.Li
(2009).
Phenotypic and molecular characterization of a novel beta-lactamase carried by Klebsiella pneumoniae, CTX-M-72, derived from CTX-M-3.
|
| |
J Gen Appl Microbiol, 55,
207-216.
|
 |
|
|
|
|
 |
T.Shimamura,
Y.Nitanai,
T.Uchiyama,
and
H.Matsuzawa
(2009).
Improvement of crystal quality by surface mutations of beta-lactamase Toho-1.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 65,
379-382.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Perez,
A.Endimiani,
K.M.Hujer,
and
R.A.Bonomo
(2007).
The continuing challenge of ESBLs.
|
| |
Curr Opin Pharmacol, 7,
459-469.
|
 |
|
|
|
|
 |
H.Hanaki,
Y.Koide,
H.Yamazaki,
R.Kubo,
T.Nakano,
K.Atsuda,
and
K.Sunakawa
(2007).
Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs).
|
| |
J Infect Chemother, 13,
390-395.
|
 |
|
|
|
|
 |
Y.Chen,
R.Bonnet,
and
B.K.Shoichet
(2007).
The acylation mechanism of CTX-M beta-lactamase at 0.88 a resolution.
|
| |
J Am Chem Soc, 129,
5378-5380.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Wang,
C.Cassidy,
and
J.C.Sacchettini
(2006).
Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
|
| |
Antimicrob Agents Chemother, 50,
2762-2771.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.S.Padayatti,
M.S.Helfand,
M.A.Totir,
M.P.Carey,
P.R.Carey,
R.A.Bonomo,
and
F.van den Akker
(2005).
High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase.
|
| |
J Biol Chem, 280,
34900-34907.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Chen,
B.Shoichet,
and
R.Bonnet
(2005).
Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.
|
| |
J Am Chem Soc, 127,
5423-5434.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Walther-Rasmussen,
and
N.Høiby
(2004).
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
|
| |
Can J Microbiol, 50,
137-165.
|
 |
|
|
|
|
 |
R.Bonnet
(2004).
Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.
|
| |
Antimicrob Agents Chemother, 48,
1.
|
 |
|
|
|
|
 |
S.Kimura,
M.Ishiguro,
Y.Ishii,
J.Alba,
and
K.Yamaguchi
(2004).
Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis.
|
| |
Antimicrob Agents Chemother, 48,
1454-1460.
|
 |
|
|
|
|
 |
C.Aumeran,
C.Chanal,
R.Labia,
D.Sirot,
J.Sirot,
and
R.Bonnet
(2003).
Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9.
|
| |
Antimicrob Agents Chemother, 47,
2958-2961.
|
 |
|
|
|
|
 |
A.S.Morin,
L.Poirel,
F.Mory,
R.Labia,
and
P.Nordmann
(2002).
Biochemical-genetic analysis and distribution of DES-1, an Ambler class A extended-spectrum beta-lactamase from Desulfovibrio desulfuricans.
|
| |
Antimicrob Agents Chemother, 46,
3215-3222.
|
 |
|
|
|
|
 |
C.Dutour,
R.Bonnet,
H.Marchandin,
M.Boyer,
C.Chanal,
D.Sirot,
and
J.Sirot
(2002).
CTX-M-1, CTX-M-3, and CTX-M-14 beta-lactamases from Enterobacteriaceae isolated in France.
|
| |
Antimicrob Agents Chemother, 46,
534-537.
|
 |
|
|
|
|
 |
I.Massova,
and
P.A.Kollman
(2002).
pKa, MM, and QM studies of mechanisms of beta-lactamases and penicillin-binding proteins: acylation step.
|
| |
J Comput Chem, 23,
1559-1576.
|
 |
|
|
|
|
 |
S.Vimont,
L.Poirel,
T.Naas,
and
P.Nordmann
(2002).
Identification of a chromosome-borne expanded-spectrum class a beta-lactamase from Erwinia persicina.
|
| |
Antimicrob Agents Chemother, 46,
3401-3405.
|
 |
|
|
|
|
 |
T.Shimamura,
A.Ibuka,
S.Fushinobu,
T.Wakagi,
M.Ishiguro,
Y.Ishii,
and
H.Matsuzawa
(2002).
Acyl-intermediate structures of the extended-spectrum class A beta-lactamase, Toho-1, in complex with cefotaxime, cephalothin, and benzylpenicillin.
|
| |
J Biol Chem, 277,
46601-46608.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.Cao,
T.Lambert,
and
P.Courvalin
(2002).
ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum beta-lactamase CTX-M-17.
|
| |
Antimicrob Agents Chemother, 46,
1212-1217.
|
 |
|
|
|
|
 |
W.Sougakoff,
G.L'Hermite,
L.Pernot,
T.Naas,
V.Guillet,
P.Nordmann,
V.Jarlier,
and
J.Delettré
(2002).
Structure of the imipenem-hydrolyzing class A beta-lactamase SME-1 from Serratia marcescens.
|
| |
Acta Crystallogr D Biol Crystallogr, 58,
267-274.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Oliver,
J.C.Pérez-Díaz,
T.M.Coque,
F.Baquero,
and
R.Cantón
(2001).
Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain.
|
| |
Antimicrob Agents Chemother, 45,
616-620.
|
 |
|
|
|
|
 |
C.Contreras-Martel,
J.Martinez-Oyanedel,
M.Bunster,
P.Legrand,
C.Piras,
X.Vernede,
and
J.C.Fontecilla-Camps
(2001).
Crystallization and 2.2 A resolution structure of R-phycoerythrin from Gracilaria chilensis: a case of perfect hemihedral twinning.
|
| |
Acta Crystallogr D Biol Crystallogr, 57,
52-60.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Lim,
F.Sanschagrin,
L.Passmore,
L.De Castro,
R.C.Levesque,
and
N.C.Strynadka
(2001).
Insights into the molecular basis for the carbenicillinase activity of PSE-4 beta-lactamase from crystallographic and kinetic studies.
|
| |
Biochemistry, 40,
395-402.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.W.Decousser,
L.Poirel,
and
P.Nordmann
(2001).
Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens.
|
| |
Antimicrob Agents Chemother, 45,
3595-3598.
|
 |
|
|
|
|
 |
L.Poirel,
T.Naas,
I.Le Thomas,
A.Karim,
E.Bingen,
and
P.Nordmann
(2001).
CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop.
|
| |
Antimicrob Agents Chemother, 45,
3355-3361.
|
 |
|
|
|
|
 |
M.Ishiguro,
T.Nishihara,
and
R.Tanaka
(2001).
[New orally active penem antibiotic: Farom]
|
| |
Yakugaku Zasshi, 121,
915-927.
|
 |
|
|
|
|
 |
P.A.Bradford
(2001).
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.
|
| |
Clin Microbiol Rev, 14,
933.
|
 |
|
|
|
|
 |
R.Bonnet,
C.Dutour,
J.L.Sampaio,
C.Chanal,
D.Sirot,
R.Labia,
C.De Champs,
and
J.Sirot
(2001).
Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.
|
| |
Antimicrob Agents Chemother, 45,
2269-2275.
|
 |
|
|
|
|
 |
H.Kurokawa,
T.Yagi,
N.Shibata,
K.Shibayama,
K.Kamachi,
and
Y.Arakawa
(2000).
A new SHV-derived extended-spectrum beta-lactamase (SHV-24) that hydrolyzes ceftazidime through a single-amino-acid substitution (D179G) in the -loop.
|
| |
Antimicrob Agents Chemother, 44,
1725-1727.
|
 |
|
|
|
|
 |
R.Bonnet,
J.L.Sampaio,
C.Chanal,
D.Sirot,
C.De Champs,
J.L.Viallard,
R.Labia,
and
J.Sirot
(2000).
A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil.
|
| |
Antimicrob Agents Chemother, 44,
3061-3068.
|
 |
|
|
|
|
 |
R.Bonnet,
J.L.Sampaio,
R.Labia,
C.De Champs,
D.Sirot,
C.Chanal,
and
J.Sirot
(2000).
A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.
|
| |
Antimicrob Agents Chemother, 44,
1936-1942.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|